Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands
Boekel, L., Atiqi, S., Leeuw, M., Hooijberg, F., Besten, Y. R., Wartena, R., Steenhuis, M., Vogelzang, E., Webers, C., Boonen, A., Gerritsen, M., Lems, W. F., Tas, S. W., van Vollenhoven, R. F., Voskuyl, A. E., van der Horst-Bruinsma, I., Nurmohamed, M., Rispens, T. & Wolbink, G., 1 Jul 2023, In: The Lancet Rheumatology. 5, 7, p. e375-e385Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study
Boekel, L., Hooijberg, F., Vogelzang, E. H., Besten, Y. R., Leeuw, M., Atiqi, S., van Vollenhoven, R. F., Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Dijkshoorn, B., Bakhlakh, S., Crooijmans, J. J., Voskuyl, A., van der Horst-Bruinsma, I. E., Lems, W., Kuijpers, T. W., van Ham, S. M., Wieske, L., Eftimov, F., & 13 others, 5 Apr 2022, In: RMD OPEN. 8, 1, 002035.Research output: Contribution to journal › Article › Academic › peer-review
Open Access10 Citations (Scopus) -
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
T2B! immunity against SARS-CoV-2 study group, 1 Jun 2022, In: The Lancet Rheumatology. 4, 6, p. e417-e429Research output: Contribution to journal › Article › Academic › peer-review
Open Access29 Citations (Scopus) -
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
Boekel, L., Hooijberg, F., Besten, Y. R., Vogelzang, E. H., Steenhuis, M., Leeuw, M., Atiqi, S., van Vollenhoven, R., Lems, W. F., Bos, W. H., Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Voskuyl, A. E., van der Horst-Bruinsma, I. E., Tas, S. W., Boers, M., Rispens, T., Nurmohamed, M. T. & Wolbink, G., 1 May 2022, In: The Lancet Rheumatology. 4, 5, p. e310-e313Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access9 Citations (Scopus) -
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., Rispens, T., & 3 others, 1 Nov 2022, In: The Lancet Rheumatology. 4, 11, p. e747-e750 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access7 Citations (Scopus)